{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:54:37Z","timestamp":1793501677274,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.jaad.2007.08.036","type":"journal-article","created":{"date-parts":[[2007,10,25]],"date-time":"2007-10-25T06:07:24Z","timestamp":1193292444000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":380,"title":["Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel"],"prefix":"10.1016","volume":"58","author":[{"given":"Sima","family":"Halevy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Dominique","family":"Ghislain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Fagot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Nico","family":"Bouwes Bavinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Sidoroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Naldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Dunant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Viboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Roujeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.08.036_bib1","unstructured":"Sweetman S, editor. Martindale: the complete drug reference [database online]. London: Pharmaceutical Press; 2006. Electronic version; Greenwood Village, Colo: Thomson Micromedex. Edition expires September 2006."},{"key":"10.1016\/j.jaad.2007.08.036_bib2","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1136\/bmj.290.6486.1969","article-title":"Asymptomatic hyperuricemia and allopurinol induced toxic epidermal necrolysis","volume":"290","author":"Aubock","year":"1985","journal-title":"Br Med J"},{"key":"10.1016\/j.jaad.2007.08.036_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/106002809302700317","article-title":"Allopurinol hypersensitivity syndrome: a review","volume":"27","author":"Arellano","year":"1993","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2007.08.036_bib4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.08.036_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2007.08.036_bib6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2007.08.036_bib7","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2007.08.036_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/heart.87.3.229","article-title":"Effect of allopurinol on mortality and hospitalizations in chronic heart failure: a retrospective cohort study","volume":"87","author":"Struthers","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.jaad.2007.08.036_bib9","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs, the EuroSCAR study","author":"Mockenhaupt","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaad.2007.08.036_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0895-4356(95)00004-N","article-title":"An international collaborative case-control study of severe cutaneous adverse reactions (SCAR): design and methods","volume":"48","author":"Kelly","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2007.08.036_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1445-5994.2005.00790.x","article-title":"Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study","volume":"35","author":"Lin","year":"2005","journal-title":"Intern Med J"},{"key":"10.1016\/j.jaad.2007.08.036_bib12","unstructured":"Klasco RK. Drugdex system [database online]. Greenwood Village, Colo: Thomson Micormedex. Edition expires September 2006."},{"key":"10.1016\/j.jaad.2007.08.036_bib13","first-page":"21","article-title":"Observations and effects of educational consults on allopurinol prescribing","volume":"45","author":"Devlin","year":"1992","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.jaad.2007.08.036_bib14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1440-1762.2000.00353.x","article-title":"Quality use of allopurinol in the elderly","volume":"20","author":"Smith","year":"2000","journal-title":"J Qual Clin Pract"},{"key":"10.1016\/j.jaad.2007.08.036_bib15","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1445-5994.2000.tb00857.x","article-title":"The optimal use of allopurinol: an audit of allopurinol use in South Auckland","volume":"30","author":"Stamp","year":"2000","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.jaad.2007.08.036_bib16","first-page":"346","article-title":"A survey of allopurinol dosage prescribing","volume":"108","author":"McClintock","year":"1995","journal-title":"N Z Med J"},{"key":"10.1016\/j.jaad.2007.08.036_bib17","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/ard.40.3.245","article-title":"Acute adverse reactions attributed to allopurinol in hospitalized patients","volume":"40","author":"McInnes","year":"1981","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2007.08.036_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/1529-0131(200101)44:1<231::AID-ANR30>3.0.CO;2-7","article-title":"Efficacy and safety of desensitization to allopurinol following cutaneous reactions","volume":"44","author":"Fam","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2007.08.036_bib19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0895-4356(97)00101-7","article-title":"Thiazide diuretics and the initiation of anti-gout therapy","volume":"50","author":"Gurwitz","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2007.08.036_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/meta.2001.19489","article-title":"Effect of furosemide on renal excretion of oxypurinol and purine bases","volume":"50","author":"Yamamoto","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.jaad.2007.08.036_bib21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3949\/ccjm.69.8.594","article-title":"Asymptomatic hyperuricemia: to treat or not to treat","volume":"69","author":"Dincer","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.jaad.2007.08.036_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/art.1780290111","article-title":"The allopurinol hypersensitivity syndrome: unnecessary morbidity and mortality","volume":"29","author":"Singer","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2007.08.036_bib23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.5694\/j.1326-5377.1989.tb128510.x","article-title":"A survey of current prescribing practices of anti-inflammatory and urate-lowering drugs in gouty arthritis in New South Wales and Queensland","volume":"151","author":"Bellamy","year":"1989","journal-title":"Med J Aust"},{"key":"10.1016\/j.jaad.2007.08.036_bib24","first-page":"1813","article-title":"Evaluation of allopurinol use in patients with gout","volume":"46","author":"Zell","year":"1989","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.jaad.2007.08.036_bib25","first-page":"115","article-title":"A survey of current prescribing practices of antiinflammatory and urate-lowering drugs in gouty arthritis","volume":"104","author":"Stuart","year":"1991","journal-title":"N Z Med J"},{"key":"10.1016\/j.jaad.2007.08.036_bib26","first-page":"156","article-title":"A review of inpatients with adverse drug reactions to allopurinol","volume":"41","author":"Khoo","year":"2000","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jaad.2007.08.036_bib27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/0895-4356(94)00244-K","article-title":"The prevalence and prophylaxis of gout in England","volume":"48","author":"Harris","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaad.2007.08.036_bib28","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/BF01796514","article-title":"Uric acid levels in southern Germany in 1989: a comparison with studies from 1962, 1971, and 1984","volume":"68","author":"Gresser","year":"1990","journal-title":"Klin Wochenschr"},{"key":"10.1016\/j.jaad.2007.08.036_bib29","unstructured":"Agence Fran\u00e7aise de Securit\u00e9 Sanitaire des Produits de Sant\u00e9. Analyse des ventes de m\u00e9dicaments aux officines et aux h\u00f4pitaux en France: 1991-2001. AFSSAPS ed, Paris 2003. Available at: http:\/\/www.agmed.sante.gouv.fr. Accessed September 18, 2007."}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207013217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207013217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:07:35Z","timestamp":1759270055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962207013217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0190962207013217"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.08.036","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}